Загрузка видео...

Не удалось загрузить видео

На главную

A scientific breakthrough is only the beginning. How can AI and automation help turn discovery into new medicine? Thermo Fisher Chairman and CEO Marc Casper joins Morgan Stanley’s Kallum Titchmarsh on Exceptional Leaders to discuss what it takes to move innovation from the lab to patients.

MorganStanley's profile picture

Morgan Stanley

757,129 subscribers

11,417 просмотров • 9 дней назад •via X (Twitter)

LIVE

Anya Rossi• Live Now

Private livecam show

Комментарии: 1

Фото профиля Shakib Hossain
Shakib Hossain7 дней назад

@thermofisher automation gonna cook in biotech

Похожие видео

How could AI and care automation shape the future of healthcare? Hear from the Co-Founder and CEO of @Hingehealth Daniel Perez alongside Morgan Stanley’s Craig Hettenbach on Exceptional Leaders.
11:07

How could AI and care automation shape the future of healthcare? Hear from the Co-Founder and CEO of @Hingehealth Daniel Perez alongside Morgan Stanley’s Craig Hettenbach on Exceptional Leaders.

Morgan Stanley

13,735 просмотров • 1 месяц назад

“Technology should not be left in the hands of a few.” On the latest Exceptional Leaders, India’s Minister for Railways, Electronics and Information Technology, Ashwini Vaishnaw, joins Morgan Stanley’s Head of India Research and Chief India Equity Strategist, Ridham Desai, to discuss why rail modernization, 5G rollout, AI ambitions are central to India’s long-term growth strategy.
13:13

“Technology should not be left in the hands of a few.” On the latest Exceptional Leaders, India’s Minister for Railways, Electronics and Information Technology, Ashwini Vaishnaw, joins Morgan Stanley’s Head of India Research and Chief India Equity Strategist, Ridham Desai, to discuss why rail modernization, 5G rollout, AI ambitions are central to India’s long-term growth strategy.

Morgan Stanley

13,562 просмотров • 1 месяц назад

Rezolve Ai CEO and Chairman Dan Wagner joined Rita Cosby on NEWSMAX to discuss the future of #AI and how intelligent automation is transforming the way businesses engage, operate, and grow. #RezolveAi #ConversationalCommerce #Newsmax #ArtificialIntelligence $RZLV
4:17

Rezolve Ai CEO and Chairman Dan Wagner joined Rita Cosby on NEWSMAX to discuss the future of #AI and how intelligent automation is transforming the way businesses engage, operate, and grow. #RezolveAi #ConversationalCommerce #Newsmax #ArtificialIntelligence $RZLV

Rezolve Ai

17,545 просмотров • 8 месяцев назад

Is AI simply the next communications medium, or does it require Christian leaders to engage in a new way? Pat Gelsinger joins Carey Nieuwhof to discuss Gloo’s mission, shaping AI for good, and how technology can help churches serve people better.
1:05

Is AI simply the next communications medium, or does it require Christian leaders to engage in a new way? Pat Gelsinger joins Carey Nieuwhof to discuss Gloo’s mission, shaping AI for good, and how technology can help churches serve people better.

Gloo

162,049 просмотров • 1 месяц назад

We’re announcing that Forus has raised a $150M Series C at a $3B valuation to build the AI network for medicine. Medicine will remain one of the world’s most important industries until humanity achieves immortality, and we are only at the beginning of a new era in what it can do. GLP-1s are changing obesity and cardiometabolic disease. Gene therapies can treat diseases at their genetic source. New cancer treatments are turning diagnoses that were once fatal into diseases people can live with. AI is enabling us to discover of new drugs even faster. But discovery is only the beginning. It still takes more than a decade and billions of dollars to turn a new molecule into an approved medicine, and once it reaches market, more than a third of patients prescribed specialty treatments never receive their first dose. Forus is creating the AI network to accelerate the entire medicine pipeline, from development and launch through prescription and treatment. We connect the companies creating medicines with the doctors who prescribe them and the patients who need them. Today, Forus supports millions of people across all 50 states and is already used by providers to treat patients in 85% of U.S. residential ZIP codes. 9 of the top 15 global biopharma companies work with us, alongside many fast-growing biotechs. Our goal is to put Forus in every doctor’s office in the country and unlock an order of magnitude more medicine for society. There is a generational opportunity to rethink how new medicine reaches people. Forus is becoming how medicine moves from discovery to treatment in America, and as we scale, we’ll become the most important company in life sciences. Forus is not constrained by capital or customer demand; we are constrained by the talent and capacity of our team. To take on the opportunity in front of us, we need exceptional engineers and operators in New York who want to move fast and help us make something that matters. Come build with us. Our Series C was led by Bain Capital Ventures, with Thrive Capital, General Catalyst, Accel, Redpoint, BoxGroup, Pear VC, Vast Ventures, and SV Angel investing alongside them.
1:59

We’re announcing that Forus has raised a $150M Series C at a $3B valuation to build the AI network for medicine. Medicine will remain one of the world’s most important industries until humanity achieves immortality, and we are only at the beginning of a new era in what it can do. GLP-1s are changing obesity and cardiometabolic disease. Gene therapies can treat diseases at their genetic source. New cancer treatments are turning diagnoses that were once fatal into diseases people can live with. AI is enabling us to discover of new drugs even faster. But discovery is only the beginning. It still takes more than a decade and billions of dollars to turn a new molecule into an approved medicine, and once it reaches market, more than a third of patients prescribed specialty treatments never receive their first dose. Forus is creating the AI network to accelerate the entire medicine pipeline, from development and launch through prescription and treatment. We connect the companies creating medicines with the doctors who prescribe them and the patients who need them. Today, Forus supports millions of people across all 50 states and is already used by providers to treat patients in 85% of U.S. residential ZIP codes. 9 of the top 15 global biopharma companies work with us, alongside many fast-growing biotechs. Our goal is to put Forus in every doctor’s office in the country and unlock an order of magnitude more medicine for society. There is a generational opportunity to rethink how new medicine reaches people. Forus is becoming how medicine moves from discovery to treatment in America, and as we scale, we’ll become the most important company in life sciences. Forus is not constrained by capital or customer demand; we are constrained by the talent and capacity of our team. To take on the opportunity in front of us, we need exceptional engineers and operators in New York who want to move fast and help us make something that matters. Come build with us. Our Series C was led by Bain Capital Ventures, with Thrive Capital, General Catalyst, Accel, Redpoint, BoxGroup, Pear VC, Vast Ventures, and SV Angel investing alongside them.

Sahir

274,426 просмотров • 1 месяц назад

Could AGI help us peer into the mysteries of the universe? 🔭 Our CEO Demis Hassabis joins host Professor Hannah Fry on our podcast to discuss the current AI hype, the next 10 years of innovation, and how he believes this technology can - and should - be developed safely. Watch their conversation ↓
51:59

Could AGI help us peer into the mysteries of the universe? 🔭 Our CEO Demis Hassabis joins host Professor Hannah Fry on our podcast to discuss the current AI hype, the next 10 years of innovation, and how he believes this technology can - and should - be developed safely. Watch their conversation ↓

Google DeepMind

229,513 просмотров • 2 лет назад

Watch Demis Hassabis and Matt Clifford discuss how AI can accelerate scientific discovery and how multimodality puts us on the path to human-level AI. Demis and Matt—thank you for your insights.
2:39

Watch Demis Hassabis and Matt Clifford discuss how AI can accelerate scientific discovery and how multimodality puts us on the path to human-level AI. Demis and Matt—thank you for your insights.

David Singleton

59,247 просмотров • 2 лет назад

Our CEO Demis Hassabis joined Alex Kantrowitz on the Big Technology podcast to discuss the next steps towards better, safer AI, why AGI could be here in less than 5 years and how we can continue to apply AI models for scientific discovery. 🔬
54:57

Our CEO Demis Hassabis joined Alex Kantrowitz on the Big Technology podcast to discuss the next steps towards better, safer AI, why AGI could be here in less than 5 years and how we can continue to apply AI models for scientific discovery. 🔬

Google DeepMind

40,210 просмотров • 1 год назад

🚀 Reshaping drug discovery – and the future of medicine – with AI. Recursion CFO Ben Taylor joined the Opto Sessions podcast from CMC Aureon to share how Recursion uses AI, lab automation, biological data, and machine learning to improve the way new medicines are discovered and developed. 💠 They discuss: ▪️How pairing AI with lab automation across biology, chemistry, and clinical technology allows us to move beyond the ~10–12% of the genome currently addressed by approved or in-trial medicines and explore the vast realm of untapped biology. ▪️How Recursion is advancing REC-4881 for patients with familial adenomatous polyposis (FAP) — a progressive condition with no approved medical therapies — after achieving Phase 2 proof-of-concept and demonstrating meaningful reductions in polyp burden. ▪️How Recursion is compressing timelines and improving efficiency with high-quality, ML-ready data to design better molecules with ~90% fewer experimental chemistries and to run smarter, faster clinical trials. 👉 Check out the full conversation:
0:58

🚀 Reshaping drug discovery – and the future of medicine – with AI. Recursion CFO Ben Taylor joined the Opto Sessions podcast from CMC Aureon to share how Recursion uses AI, lab automation, biological data, and machine learning to improve the way new medicines are discovered and developed. 💠 They discuss: ▪️How pairing AI with lab automation across biology, chemistry, and clinical technology allows us to move beyond the ~10–12% of the genome currently addressed by approved or in-trial medicines and explore the vast realm of untapped biology. ▪️How Recursion is advancing REC-4881 for patients with familial adenomatous polyposis (FAP) — a progressive condition with no approved medical therapies — after achieving Phase 2 proof-of-concept and demonstrating meaningful reductions in polyp burden. ▪️How Recursion is compressing timelines and improving efficiency with high-quality, ML-ready data to design better molecules with ~90% fewer experimental chemistries and to run smarter, faster clinical trials. 👉 Check out the full conversation:

Recursion

98,892 просмотров • 3 месяцев назад

What if you could control a robotic arm simply by speaking to it? A new demo from Swiss startup Forgis explores how agentic AI on the edge can turn natural-language commands into physical action, leveraging the Arduino UNO Q board. Read our latest blog post to see what happens when voice, AI, and industrial automation come together!
0:33

What if you could control a robotic arm simply by speaking to it? A new demo from Swiss startup Forgis explores how agentic AI on the edge can turn natural-language commands into physical action, leveraging the Arduino UNO Q board. Read our latest blog post to see what happens when voice, AI, and industrial automation come together!

Arduino

18,585 просмотров • 1 месяц назад

The AI boom is spreading beyond Big Tech… Braze CEO Bill Magnuson joins to discuss how the customer engagement platform is leveraging the technology in a safe and responsible way to help brands grow their base.
3:29

The AI boom is spreading beyond Big Tech… Braze CEO Bill Magnuson joins to discuss how the customer engagement platform is leveraging the technology in a safe and responsible way to help brands grow their base.

Squawk on the Street

21,429 просмотров • 3 лет назад

We are building autonomous scientific discovery. And it runs 370x faster than a human scientist. Our AI agents index millions of scientific publications and learn what an entire field has done in the time it takes a researcher to read one paper. Then we bring it to the lab to verify and further fuel learnings. 10 years to discover a material? Not here.
0:32

We are building autonomous scientific discovery. And it runs 370x faster than a human scientist. Our AI agents index millions of scientific publications and learn what an entire field has done in the time it takes a researcher to read one paper. Then we bring it to the lab to verify and further fuel learnings. 10 years to discover a material? Not here.

Radical AI

85,437 просмотров • 6 месяцев назад

AMD CTO Mark Papermaster sits down with Sean McClain, Founder and CEO of Absci, to discuss the future of drug discovery, and how AI is revolutionizing this process. Hear how AI is accelerating innovation, cutting costs, and paving the way for personalized medication. Tune in now:
0:46

AMD CTO Mark Papermaster sits down with Sean McClain, Founder and CEO of Absci, to discuss the future of drug discovery, and how AI is revolutionizing this process. Hear how AI is accelerating innovation, cutting costs, and paving the way for personalized medication. Tune in now:

AMD

14,834 просмотров • 1 год назад

We’re proud to partner with Google Cloud to help shape the future of biopharmaceutical innovation with AI-enabled enterprise transformation. This collaboration is about unlocking new value: accelerating discovery, modernizing how we work and empowering our teams to focus on the highest-impact science and solutions for patients. Learn more about the landmark partnership:
0:35

We’re proud to partner with Google Cloud to help shape the future of biopharmaceutical innovation with AI-enabled enterprise transformation. This collaboration is about unlocking new value: accelerating discovery, modernizing how we work and empowering our teams to focus on the highest-impact science and solutions for patients. Learn more about the landmark partnership:

Merck

10,157 просмотров • 5 месяцев назад

Rippling AI Lab is now live in Bengaluru! Our new AI engineering hub is focused on building trusted AI for businesses, from agents and models to the infrastructure, evaluations, and sandboxing. Bengaluru has been central to Rippling’s engineering story from the beginning. Rippling AI Lab will help shape the next generation of AI-powered business software.
2:11

Rippling AI Lab is now live in Bengaluru! Our new AI engineering hub is focused on building trusted AI for businesses, from agents and models to the infrastructure, evaluations, and sandboxing. Bengaluru has been central to Rippling’s engineering story from the beginning. Rippling AI Lab will help shape the next generation of AI-powered business software.

Rippling

118,956 просмотров • 23 дней назад

AI agents are coming and they need serious compute. On the CES keynote stage, OpenAI President and Co-founder Greg Brockman (Greg Brockman) joined AMD Chair and CEO Lisa Su to share how AI is evolving from simple prompts to always-on agents transforming healthcare, enterprise, and scientific discovery. AMD Instinct MI455X is built for what comes next.
2:00

AI agents are coming and they need serious compute. On the CES keynote stage, OpenAI President and Co-founder Greg Brockman (Greg Brockman) joined AMD Chair and CEO Lisa Su to share how AI is evolving from simple prompts to always-on agents transforming healthcare, enterprise, and scientific discovery. AMD Instinct MI455X is built for what comes next.

AMD

25,550 просмотров • 8 месяцев назад

Normalize disabilities and recognize the work it takes to move forward. You can turn this into a beautiful thing Chrisean
1:19

Normalize disabilities and recognize the work it takes to move forward. You can turn this into a beautiful thing Chrisean

🎪

21,934 просмотров • 9 месяцев назад

A packed week in Brazil 🇧🇷 Blockchain.RIO. The Leaders Event. The Cardano booth. A private dinner. Conversations with government, industry, academia and builders. The focus throughout: what it takes to move new technology from pilots into day-to-day use.
1:46

A packed week in Brazil 🇧🇷 Blockchain.RIO. The Leaders Event. The Cardano booth. A private dinner. Conversations with government, industry, academia and builders. The focus throughout: what it takes to move new technology from pilots into day-to-day use.

Cardano Foundation

30,207 просмотров • 1 месяц назад